Blueprint Medicines Corporation (BPMC) Social Stream



Blueprint Medicines Corporation (BPMC): $60.15

3.77 (+6.69%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BPMC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 396

in industry

Blueprint Medicines Corp (BPMC) Price Targets From Analysts

Use the tables below to see what analysts covering Blueprint Medicines Corp think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 9 $136 $84 $113.222 $66.56 70.11%
2021-11-10 9 $136 $84 $114.444 $66.56 71.94%
2021-11-19 9 $136 $84 $115.777 $66.56 73.94%
2021-11-29 9 $136 $84 $115.555 $66.56 73.61%
2022-01-12 9 $135 $84 $113.333 $66.56 70.27%
2022-01-25 9 $135 $84 $110.555 $66.56 66.1%
2022-01-31 9 $135 $84 $108.444 $66.56 62.93%
2022-02-08 9 $135 $84 $104.777 $66.56 57.42%
2022-02-17 9 $133 $82 $100.625 $66.56 51.18%
2022-03-01 10 $133 $71 $97.333 $66.56 46.23%
2022-03-22 10 $133 $71 $97.888 $66.56 47.07%

The Trend in the Analyst Price Target


Over the past 18 months, BPMC's average price target has gone down $4.11.

Over the past 48 weeks, BPMC's average upside potential has been 31.01%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-22 14 152 81 117.620 94.40 24.6%
2021-07-15 13 152 81 119.690 81.28 47.26%
2021-11-09 9 136 84 113.222 114.95 -1.5%
2021-11-29 9 136 84 115.555 98.28 17.58%
2022-02-08 9 135 84 104.777 80.51 30.14%

BPMC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 5 0 5 0 0 10

The Trend in the Broker Recommendations


Over the past 26 weeks, BPMC's average broker recommendation rating worsened by 0.14.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, Blueprint Medicines Corp's average analyst price target is higher than 908.37% of them.
  • In terms of how Blueprint Medicines Corp fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 924.2% of that group.
  • Blueprint Medicines Corp's upside potential (average analyst target price relative to current price) is greater than 309.86% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, Blueprint Medicines Corp's variance in analysts' estimates is lower than -677.92% of them.

Stocks similar to Blueprint Medicines Corp in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BHVN, BBIO, and AXSM.

Make investment decisions regarding BPMC using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.471 seconds.